New data on metasomatic processes in the lithospheric mantle in the central part of the Arkhangelsk diamondiferous province (ADP) are presented. We studied the major- and trace-element compositions of minerals of 26 garnet peridotite xenoliths from the V. Grib kimberlite pipe; 17 xenoliths contained phlogopite. Detailed mineralogical, petrographic, and geochemical studies of peridotite minerals (garnet, clinopyroxene, and phlogopite) have revealed two types of modal metasomatic enrichment of the lithospheric-mantle rocks: high temperature (melt) and low-temperature (phlogopite). Both types of modal metasomatism significantly changed the chemical composition of the peridotites. Low-temperature modal metasomatism manifests itself as coarse tabular and shapeless phlogopite grains. Two textural varieties of phlogopite show significant differences in chemical composition, primarily in the contents of TiO2, Cr2O3, FeO, Ba, Rb, and Cs. The rock-forming minerals of phlogopite-bearing peridotites differ in chemical composition from phlogopite-free peridotites, mainly in higher FeO content. Most garnets and clinopyroxenes in peridotites are the products of high-temperature mantle metasomatism, as indicated by the high contents of incompatible elements and REE pattern in these minerals. Fractional-crystallization modeling gives an insight into the nature of melts (metasomatic agents). They are close in composition to picrites of the Izhmozero field, basalts of the Tur’ino field, and carbonatites of the Mela field of the ADP. The REE patterns of the peridotite minerals make it possible to determine the sequence of metasomatic enrichment of the lithospheric mantle beneath the V. Grib kimberlite pipe.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.